| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Townson Sharon is a Chief Scientific Officer at GLUE. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $1.6M at current prices.
Townson Sharon's largest disclosed position is in GLUE as Chief Scientific Officer, worth about $1.6M. The recent filings there lean toward selling, a net 21,155 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,000 | $23.31 | $139,849.20 | -8.1% | - | - | |
| Jun 23, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,000 | $20.00 | $60,000.00 | -4.2% | - | - | |
| Jun 17, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,000 | $19.00 | $57,000.00 | -4.2% | - | - | |
| May 29, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 6,000 | $19.87 | $119,220.00 | -8.1% | - | - | |
| Jan 5, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,155 | $15.17 | $47,861.35 | -4.4% | +17.6% | - |